PET/MRI Promising for Esophageal Cancer Staging
Preoperative imaging of patients with esophageal cancer by PET and MRI may provide higher accuracy in nodal staging.
Compared with endoscopic ultrasound (EUS), PET/MR imaging may provide higher accuracy in nodal staging of esophageal cancer, according to a study published in the Journal of Nuclear Medicine.
Researchers from Pusan National University Hospital in Korea undertook a prospective study to compare the results of EUS, CT, PET/MR imaging and PET/CT for the preoperative local and regional staging of esophageal cancer, with postoperative pathologic stage used as the reference standard.
Nineteen patients (15 men) with newly diagnosed resectable esophageal cancer participated in the study. All underwent preoperative EUS, CT, PET/CT and PET/MR imaging. The images were reviewed by a chest radiologist and nuclear medicine physician, who assigned tumor and lymph node stages.
Findings for accurate staging were as follows:
While the study was small and limited, “PET/MR imaging demonstrated acceptable accuracy for T staging compared with EUS and, although not statistically significant, even higher accuracy than EUS and PET/CT for prediction of N staging,” the authors wrote.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
Can a Six-Minute MRI Facilitate Detection of Multiple Sclerosis?
May 23rd 2025Recognition of the central vein sign with a six-minute MRI demonstrated comparable sensitivity for multiple sclerosis (MS) detection in comparison to oligoclonal band (OCB) assessment, which requires lumbar puncture, according to newly published research.
CT Perfusion Study Shows Enhanced Detection of Medium Vessel Occlusions with Emerging AI Software
May 21st 2025The Rapid CTP AI software offered 23 percent greater detection of medium vessel occlusions in comparison to the Viz CTP AI software, according to research presented at the European Stroke (Organization) Conference (ESOC).
